Qualitop H2020

qualitop aims at developing a european immunotherapy-specific open smart digital platform and using big data analysis, artificial intelligence, and simulation modelling approaches. this will enable collecting and aggregating efficiently real-world data to monitor health status and qol of cancer patients given immunotherapy. through causal inference analyses, qualitop will identify the determinants of health status regarding ir-aes and define patient profiles in a real-world context. for this, heterogeneous data sources (big data), both retrospective and prospective –collected for qualitop from clinical centres in four eu countries—will integrate lifestyle, genetic, and psychosocial determinants of qol. using machine learning approaches, qualitop will provide “real-time” recommendations stemming from patient profiles and feedbacks via the smart digital platform. furthermore, an increased visibility on patients’ behaviour, a better ir-aes prediction, and an improvement of care coordinati